222 related articles for article (PubMed ID: 22750225)
1. The polymorphism p.G219R of CD40L does not cause immunological alterations in vivo: conclusions from a X-linked hyper IgM syndrome kindred.
Martinez-Martinez L; Gonzalez-Santesteban C; Badell I; de la Calle-Martin O
Mol Immunol; 2012 Oct; 52(3-4):237-41. PubMed ID: 22750225
[TBL] [Abstract][Full Text] [Related]
2. Clinical and molecular characterization of X-linked hyper-IgM syndrome patients in China.
An Y; Xiao J; Jiang L; Yang X; Yu J; Zhao X
Scand J Immunol; 2010 Jul; 72(1):50-6. PubMed ID: 20591076
[TBL] [Abstract][Full Text] [Related]
3. Hyper-immunoglobulin M syndrome caused by a mutation in the promotor for CD40L.
Van Hoeyveld E; Zhang PX; De Boeck K; Fuleihan R; Bossuyt X
Immunology; 2007 Apr; 120(4):497-501. PubMed ID: 17244160
[TBL] [Abstract][Full Text] [Related]
4. X-linked hyper-IgM syndrome with CD40LG mutation: two case reports and literature review in Taiwanese patients.
Tsai HY; Yu HH; Chien YH; Chu KH; Lau YL; Lee JH; Wang LC; Chiang BL; Yang YH
J Microbiol Immunol Infect; 2015 Feb; 48(1):113-8. PubMed ID: 23010537
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells from X-linked hyper-IgM patients present impaired responses to Candida albicans and Paracoccidioides brasiliensis.
Cabral-Marques O; Arslanian C; Ramos RN; Morato M; Schimke L; Soeiro Pereira PV; Jancar S; Ferreira JF; Weber CW; Kuntze G; Rosario-Filho NA; Costa Carvalho BT; Bergami-Santos PC; Hackett MJ; Ochs HD; Torgerson TR; Barbuto JA; Condino-Neto A
J Allergy Clin Immunol; 2012 Mar; 129(3):778-86. PubMed ID: 22154528
[TBL] [Abstract][Full Text] [Related]
6. De novo mutation causing X-linked hyper-IgM syndrome: a family study in Taiwan.
Ma YC; Lee WI; Shyur SD; Lin SC; Huang LH; Wu JY
Asian Pac J Allergy Immunol; 2005 Mar; 23(1):53-9. PubMed ID: 15997875
[TBL] [Abstract][Full Text] [Related]
7. Signaling through CD40 rescues IgE but not IgG or IgA secretion in X-linked immunodeficiency with hyper-IgM.
Saiki O; Tanaka T; Wada Y; Uda H; Inoue A; Katada Y; Izeki M; Iwata M; Nunoi H; Matsuda I
J Clin Invest; 1995 Feb; 95(2):510-4. PubMed ID: 7532185
[TBL] [Abstract][Full Text] [Related]
8. X-linked hyper-immunoglobulin M syndrome harboring a novel CD40-ligand gene mutation: a case report.
Ramachandran R; Krishnan Y; Singh P; Kumar A; Mohanty A
Immunogenetics; 2023 Apr; 75(2):191-194. PubMed ID: 36478253
[TBL] [Abstract][Full Text] [Related]
9. Targeted gene editing restores regulated CD40L function in X-linked hyper-IgM syndrome.
Hubbard N; Hagin D; Sommer K; Song Y; Khan I; Clough C; Ochs HD; Rawlings DJ; Scharenberg AM; Torgerson TR
Blood; 2016 May; 127(21):2513-22. PubMed ID: 26903548
[TBL] [Abstract][Full Text] [Related]
10. Mutations of CD40 ligand in two patients with hyper-IgM syndrome.
García-Pérez MA; Paz-Artal E; Corell A; Moreno A; López-Goyanes A; García-Martín F; Vázquez R; Pacho A; Romo E; Allende LM
Immunobiology; 2003; 207(4):285-94. PubMed ID: 12952351
[TBL] [Abstract][Full Text] [Related]
11. X-linked hyper IgM syndrome: clinical, immunological and molecular features in patients from India.
Madkaikar M; Gupta M; Chavan S; Italia K; Desai M; Merchant R; Radhakrishnan N; Ghosh K
Blood Cells Mol Dis; 2014 Sep; 53(3):99-104. PubMed ID: 24929972
[TBL] [Abstract][Full Text] [Related]
12. [From gene to disease; CD40 ligand deficiency as the cause of X-linked hyper-IgM-syndrome].
Groeneweg M; Lankester AC; Bredius RG
Ned Tijdschr Geneeskd; 2003 May; 147(21):1009-11. PubMed ID: 12811971
[TBL] [Abstract][Full Text] [Related]
13. Genetic Analysis of Patients with Two Different Types of Hyper IgM Syndrome.
Alizadeh Z; Mazinani M; Houshmand M; Shakerian L; Nourizadeh M; Pourpak Z; Fazlollahi MR
Immunol Invest; 2018 Oct; 47(7):745-753. PubMed ID: 30081731
[TBL] [Abstract][Full Text] [Related]
14. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients.
Winkelstein JA; Marino MC; Ochs H; Fuleihan R; Scholl PR; Geha R; Stiehm ER; Conley ME
Medicine (Baltimore); 2003 Nov; 82(6):373-84. PubMed ID: 14663287
[TBL] [Abstract][Full Text] [Related]
15. Somatic mutations in human Ig variable genes correlate with a partially functional CD40-ligand in the X-linked hyper-IgM syndrome.
Razanajaona D; van Kooten C; Lebecque S; Bridon JM; Ho S; Smith S; Callard R; Banchereau J; Brière F
J Immunol; 1996 Aug; 157(4):1492-8. PubMed ID: 8759730
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of patients with X-linked Hyper-IgM syndrome: description of two novel CD40L mutations.
Rangel-Santos A; Wakim VL; Jacob CM; Pastorino AC; Cunha JM; Collanieri AC; Niemela JE; Grumach AS; Duarte AJ; Moraes-Vasconcelos D; Oliveira JB
Scand J Immunol; 2009 Feb; 69(2):169-73. PubMed ID: 19170966
[TBL] [Abstract][Full Text] [Related]
17. X-linked hyper IgM syndrome: a novel sequence variant associated with an atypical mild phenotype.
Buchbinder D; Park S; Nugent D
J Pediatr Hematol Oncol; 2012 Jul; 34(5):e212-4. PubMed ID: 22322937
[TBL] [Abstract][Full Text] [Related]
18. A novel mutation in the CD40 ligand gene in a Chinese boy with X-linked hyper-IgM syndrome.
Liu PN; Li H; Li Q; Yin ZW; Zhou CY; Jiang MY; Guo X
Asian Pac J Allergy Immunol; 2014 Sep; 32(3):270-4. PubMed ID: 25268346
[TBL] [Abstract][Full Text] [Related]
19. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans.
Weller S; Faili A; Garcia C; Braun MC; Le Deist F F; de Saint Basile G G; Hermine O; Fischer A; Reynaud CA; Weill JC
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1166-70. PubMed ID: 11158612
[TBL] [Abstract][Full Text] [Related]
20. A novel CD40LG deletion causes the hyper-IgM syndrome with normal CD40L expression in a 6-month-old child.
López-Herrera G; Maravillas-Montero JL; Vargas-Hernández A; Berrón-Ruíz L; Ramírez-Sánchez E; Yamazaki-Nakashimada MA; Espinosa-Rosales FJ; Santos-Argumedo L
Immunol Res; 2015 May; 62(1):89-94. PubMed ID: 25752457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
